Name of Patient

B. V.

Age

20 y.o

Height

52

Diagnosis

G1P1 PU 31 wks. AOG/LMP cephalic, IPTL, severe

preeclampsia with pulmonary congestion
M. M. Olmillo

Sex

Female

Weight

60 kg

Website

milkv.co.vu

A/N

Youre welcome

Author

DRUG DATA
Generic name:
Multivitamins +
FeSO4

CLASSIFICATION
Pharmacologic:
Water-soluble
vitamins, iron
supplements

Trade name/s:
Mulvitron
Patients dose:
1 tab OD
Minumum dose:
125 mg

Therapeutic:
Vitamins & minerals,
antianemics

MECHANISM OF
ACTION

An essential mineral
found in haemoglobin,
myoglobin, and many
enzymes. Enters the
bloodstream and is
transported to the
organs of the
reticuloendothelial
system (liver, spleen,
bone marrow), where it
is separated out and
becomes part of iron
stores.

Maximum dose:
750 mg
Pregnancy Category
Risk: A
Availability:
Tablets 150,
200, 500mg;
capsules 300,
500mg; syrups
250mg/5mL
Route:
PO

INDICATION

General
indications:
Prevention and
treatment of ironvitamin and
dietary deficiency
anemias; used in
anemia due to
blood loss during
menstruation,
infections,
surgery, delivery,
intoxications,
parasitosis, or
other causes &
anemias during
pregnancy

Onset: 4 days
Peak: 7-10 days
Duration: 2-4 months
Metabolism: mostly
recycled, small daily
losses
Distribution: crosses
placenta, enters breast
milk
Excretion: sweat,
urine, bile

Patients actual
indication:
MV + FeSO4 is
prescribed for
postpartum
patients to
prevent the
occurrence of
pregnancyinduced anemia
and keep her
nutritionally
balanced.

CONTRAINDICATI
ON

Hemochromatosis,
hemosiderosis, or other
evidence of iron
overload; anemias not
due to iron deficiency
Precautions:
Use cautiously in peptic
ulcer, ulcerative colitis or
regional enteritis,
alcoholism, severe
hepatic impairment,
severe renal impairment,
rheumatoid arthritis,
pregnancy or lactation
Interaction:
Drug-drug: antacids that
contain calcium.
tatracylcines,
biphosphates, H2
antagonists, protonpump inhibitors
Drug-food: iron
absorption is decreased
33-50% by concurrent
administration of food

ADVERSE
EFFECTS

CNS: seizures,
dizziness,
headaches,
syncope
CV: hypotension,
hypertension,
tachycardia
GI: nausea,
constipation, dark
stools, diarrhea,
vomiting
Dermatologic:
flushing, urticaria
Respiratory:
cough, dyspnea
MS: arthralgia,
myalgia
Local: pain at IM
site
Others: staining of
teeth, anaphylaxis,
sweating

NURSING
RESPONSIBILITIE
S

Before:
> monitor blood studies of patient
> observe proper dosage of
medication
> note other drugs patient is taking to
avoid possible interactions
> verify the patients identity
During:
> most effectively absorbed if
administered 1 or 2 hrs before meal
> take with a full glass of water/juice
> do not crush/chew enteric-coated
tablets and do not open capsules
> encourage patient to avoid using
antacids, coffee, tea, dairy products
within 1 hour after
> inform patient about dark, green or
black stools to avoid panic
After:
> monitor pts blood studies
> inform patient about what possible
adverse effects that may occur
> assess bowel function for
constipation/diarrhea
> document and record.

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source:
2011 Lippincotts Nursing Drug Guide